|
JP4598954B2
(ja)
*
|
1998-10-20 |
2010-12-15 |
フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） |
大腸炎処置のためのサイトカイン産生性ラクトコッカス株の使用
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
DK1311269T3
(da)
*
|
2000-08-04 |
2012-03-26 |
Dmi Biosciences Inc |
Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
AU2003279761B2
(en)
*
|
2002-10-02 |
2009-11-12 |
Luoxis Diagnostics, Inc. |
Diagnosis and monitoring of diseases
|
|
AU2003298291A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Universiteit Gent |
Self-containing lactobacillus strain
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
ES2572975T3
(es)
|
2003-05-15 |
2016-06-03 |
Ampio Pharmaceuticals, Inc. |
Tratamiento de enfermedades mediadas por los linfocitos T
|
|
GB2422373B
(en)
*
|
2003-08-18 |
2008-05-21 |
Btg Int Ltd |
Treatment of neurodegenerative conditions
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
EP1718602A4
(en)
*
|
2004-01-30 |
2007-12-12 |
Peplin Biolipids Pty Ltd |
THERAPEUTIC AND CARRIER MOLECULES
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
AU2006319216B2
(en)
|
2005-11-29 |
2012-09-13 |
Intrexon Actobiotics Nv |
Induction of mucosal tolerance to antigens
|
|
CA3037889C
(en)
|
2007-01-25 |
2022-09-13 |
Intrexon Actobiotics Nv |
Treatment of immune disease by mucosal delivery of antigens
|
|
AU2008274876A1
(en)
*
|
2007-02-05 |
2009-01-15 |
Children, Youth And Women's Health Service |
Modulators of antigen-dependent T cell proliferation
|
|
EP2217224B1
(en)
|
2007-11-09 |
2019-05-08 |
Basf As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
JP5856843B2
(ja)
*
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
AR078507A1
(es)
*
|
2009-05-08 |
2011-11-16 |
Pronova Biopharma Norge As |
Compuestos lipidicos, composiciones farmaceuticas, usos y metodo de preparacion
|
|
GB0909643D0
(en)
*
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
*
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
EP2613786A4
(en)
|
2010-09-07 |
2013-10-23 |
Dmi Acquisition Corp |
TREATMENT OF DISEASES
|
|
KR20200034814A
(ko)
|
2010-11-05 |
2020-03-31 |
바스프 에이에스 |
지질 화합물을 이용한 치료방법
|
|
US9925300B2
(en)
|
2011-10-10 |
2018-03-27 |
Ampio Pharmaceuticals, Inc. |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
|
PH12014500685B1
(en)
|
2011-10-10 |
2018-10-03 |
Ampio Pharmaceuticals Inc |
Treatment of degenerative joint disease
|
|
JP6231484B2
(ja)
|
2011-10-28 |
2017-11-15 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
鼻炎の処置
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
EP2833738B1
(en)
|
2012-03-30 |
2019-10-30 |
Givaudan S.A. |
N-acylated methionine derivatives as food flavouring compounds
|
|
EP2830438B1
(en)
|
2012-03-30 |
2019-09-04 |
Givaudan SA |
N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds, powder compositions containing them
|
|
SG11201405104PA
(en)
|
2012-03-30 |
2014-10-30 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
KR102068375B1
(ko)
|
2012-03-30 |
2020-01-20 |
지보당 에스아 |
향미 프로파일 식용 조성물의 개선을 위한 n-아실-아미노산 유도체
|
|
EP2830441B1
(en)
|
2012-03-30 |
2019-11-13 |
Givaudan SA |
N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds
|
|
CA2868073C
(en)
|
2012-03-30 |
2020-12-29 |
Givaudan S.A. |
N-acyl proline derivatives as food flavouring compounds
|
|
WO2013148997A1
(en)
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds
|
|
GB201221329D0
(en)
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
WO2014132134A1
(en)
|
2013-02-28 |
2014-09-04 |
Pronova Biopharma Norge As |
A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
CN105101965B
(zh)
|
2013-03-15 |
2021-03-09 |
安皮奥制药股份有限公司 |
用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法
|
|
CN105592719B
(zh)
|
2013-10-02 |
2020-03-10 |
奇华顿股份有限公司 |
有机化合物
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
US11122826B2
(en)
|
2013-10-02 |
2021-09-21 |
Givaudan Sa |
Organic compounds
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
US20160227825A1
(en)
|
2013-10-02 |
2016-08-11 |
Givaudan Sa |
Organic Compounds having Taste-Modifying Properties
|
|
WO2015050534A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
CN105658089B
(zh)
|
2013-10-02 |
2019-07-09 |
奇华顿股份有限公司 |
有机化合物
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
JP6723222B2
(ja)
|
2014-08-18 |
2020-07-15 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
関節病態の治療
|
|
JP6784696B2
(ja)
|
2015-04-28 |
2020-11-11 |
プロノヴァ バイオファーマ ノルゲ エーエス |
硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び／又は治療のための使用
|
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
|
US11690825B2
(en)
|
2016-03-09 |
2023-07-04 |
Board Of Regents, The University Of Texas System |
20-HETE receptor (GPR75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
EP3515422A1
(en)
|
2016-09-21 |
2019-07-31 |
Avexxin AS |
Pharmaceutical composition
|
|
MX2020005621A
(es)
|
2017-12-06 |
2020-08-20 |
Basf As |
Derivados de acidos grasos para tratar la esteatohepatitis no alcoholica.
|